- Home
- VTSI vs MAIA Comparison
VTSI vs MAIA Comparison
Compare VTSI & MAIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VTSI
- MAIA
- Stock Information
- Founded
- VTSI 1993
- MAIA 2018
- Country
- VTSI United States
- MAIA United States
- Employees
- VTSI N/A
- MAIA N/A
- Industry
- VTSI Miscellaneous manufacturing industries
- MAIA Biotechnology: Pharmaceutical Preparations
- Sector
- VTSI Consumer Discretionary
- MAIA Health Care
- Exchange
- VTSI Nasdaq
- MAIA Nasdaq
- Market Cap
- VTSI 70.9M
- MAIA 62.4M
- IPO Year
- VTSI N/A
- MAIA 2022
- Fundamental
- Price
- VTSI $6.48
- MAIA $2.82
- Analyst Decision
- VTSI Strong Buy
- MAIA
- Analyst Count
- VTSI 2
- MAIA 0
- Target Price
- VTSI $14.50
- MAIA N/A
- AVG Volume (30 Days)
- VTSI 62.2K
- MAIA 60.0K
- Earning Date
- VTSI 11-12-2024
- MAIA 11-05-2024
- Dividend Yield
- VTSI N/A
- MAIA N/A
- EPS Growth
- VTSI 52.41
- MAIA N/A
- EPS
- VTSI 0.63
- MAIA N/A
- Revenue
- VTSI $31,848,960.00
- MAIA N/A
- Revenue This Year
- VTSI N/A
- MAIA N/A
- Revenue Next Year
- VTSI $28.48
- MAIA N/A
- P/E Ratio
- VTSI $10.18
- MAIA N/A
- Revenue Growth
- VTSI N/A
- MAIA N/A
- 52 Week Low
- VTSI $4.57
- MAIA $0.82
- 52 Week High
- VTSI $17.68
- MAIA $5.99
- Technical
- Relative Strength Index (RSI)
- VTSI 56.57
- MAIA 50.98
- Support Level
- VTSI $6.28
- MAIA $2.36
- Resistance Level
- VTSI $6.70
- MAIA $2.72
- Average True Range (ATR)
- VTSI 0.25
- MAIA 0.22
- MACD
- VTSI 0.04
- MAIA 0.02
- Stochastic Oscillator
- VTSI 77.03
- MAIA 72.28
About VTSI VirTra Inc.
VirTra Inc is a U.S.-based company that is engaged in the sale and development of the judgmental use of force training simulators and firearms training simulators for law enforcement, military and commercial uses. It sells simulators and related products across the globe through a direct sales force and international distribution partners. The services provided by the company includes installation, training, limited warranties, service agreements and related support. The company sells and supports use of force training and marksmanship firearms training systems and accessories for law enforcement, military or civilian use. The product line of the company includes simulators, upgrade components, scenarios, scenario software, recoil kits, Threat Fire and other accessories.
About MAIA MAIA Biotechnology Inc.
MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company. The company develops targeted immunotherapies for cancer. The company is an immune-oncology company, focused on the development of first-in-class drugs with novel mechanisms of action that are intended to meaningfully improve and extend the lives of people with cancer. The company's program is THIO, a potential cancer telomere-targeting agent in clinical development for the treatment of telomerase-positive cancer cells.